- Home
- SGMO vs MNSB Comparison
SGMO vs MNSB Comparison
Compare SGMO & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- MNSB
- Stock Information
- Founded
- SGMO 1995
- MNSB 2003
- Country
- SGMO United States
- MNSB United States
- Employees
- SGMO N/A
- MNSB N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- MNSB Major Banks
- Sector
- SGMO Health Care
- MNSB Finance
- Exchange
- SGMO Nasdaq
- MNSB Nasdaq
- Market Cap
- SGMO 122.8M
- MNSB 140.1M
- IPO Year
- SGMO 2000
- MNSB N/A
- Fundamental
- Price
- SGMO $0.45
- MNSB $18.50
- Analyst Decision
- SGMO Buy
- MNSB
- Analyst Count
- SGMO 7
- MNSB 0
- Target Price
- SGMO $4.71
- MNSB N/A
- AVG Volume (30 Days)
- SGMO 4.6M
- MNSB 41.9K
- Earning Date
- SGMO 11-06-2025
- MNSB 10-27-2025
- Dividend Yield
- SGMO N/A
- MNSB 2.14%
- EPS Growth
- SGMO N/A
- MNSB N/A
- EPS
- SGMO N/A
- MNSB N/A
- Revenue
- SGMO $32,875,000.00
- MNSB $69,367,000.00
- Revenue This Year
- SGMO $28.47
- MNSB $23.19
- Revenue Next Year
- SGMO N/A
- MNSB $2.92
- P/E Ratio
- SGMO N/A
- MNSB N/A
- Revenue Growth
- SGMO N/A
- MNSB 9.71
- 52 Week Low
- SGMO $0.41
- MNSB $15.00
- 52 Week High
- SGMO $2.84
- MNSB $22.98
- Technical
- Relative Strength Index (RSI)
- SGMO 29.91
- MNSB 45.70
- Support Level
- SGMO $0.42
- MNSB $17.86
- Resistance Level
- SGMO $0.53
- MNSB $18.53
- Average True Range (ATR)
- SGMO 0.04
- MNSB 0.46
- MACD
- SGMO -0.01
- MNSB 0.07
- Stochastic Oscillator
- SGMO 11.96
- MNSB 52.40
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.